As of 9:30 AM on the 18th, Celltrion Healthcare is trading at 159,600 KRW, up 0.5% from the previous day. This marks a 61.7% increase compared to November 20. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

Over the past five days, individual investors have net purchased 131,613 shares, while foreigners and institutions have net sold 10,937 shares and 94,237 shares, respectively.



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing